11 results
COVID-19 on Lung POCUS - Day 2

Day 2 after COVID diagnosis. Less sore throat, cough &
COVID-19 on Lung ... diagnosis. ... Thickening #COVID19 #clinical ... #pulmonary #BLines ... #POCUS #Effusion
COVID-19 Intubation Checklist

Personal protective equipment (PPE)
 • Standard PPE
   • N95 or PAPR.
COVID-19 Intubation ... Checklist Personal ... on exhalation port ... using BVM: Hold mask ... #SARSCoV2 #Management
COVID-19 - Subpleural Consolidations on Lung POCUS

Doing daily POCUS LUS for ICU COVID-19 patients in Singapore
COVID-19 - Subpleural ... Helps with management ... conserve valuable PPEs ... Consolidations #COVID19 #clinical ... #pulmonary #POCUS
Blastomycosis (Blastomyces): Gilchrist’s disease, Chicago disease - Summary Sheet
 • Morphology
 • Geography, Reservoir and Mode
inoculation • Clinical ... small pleural effusions ... presentation of TB, lung ... • Management ... #fungal
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Thromboendarterectomy
Chronic Thromboembolic Pulmonary Hypertension
Definition: mean pulmonary-artery pressure > 25mmHg
Plexiform-lesion formation Clinical ... 6 months after PE ... • Ventilation-perfusion ... lung scanning showing ... #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
infection (NTM) • Fungal ... characteristic features Clinical ... Tuberculosis Diagnosis ... assay (IGRA) • PPD ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
infection (NTM) • Fungal ... characteristic features Clinical ... Tuberculosis Diagnosis ... assay (IGRA) • PPD ... #Management #Treatment
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... ATS/STS/STR Clinical ... goals of assessing lung ... Predicted very short ... #Pleural #Pulmonary
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
thickening or effusion ... , INC risk PE, Pulmonary ... phenomenon (16%) MSK ... MALT Lymphoma • Lung ... #Management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Evaluation Major Pre-Op ... Change in clinical ... unless prior heart/lung ... medical and surgical management ... stratification #diagnosis